TELA Bio (TELA) Change in Acquisitions & Divestments (2020)
TELA Bio (TELA) recorded quarterly Change in Acquisitions & Divestments of $5.3 million in Q2 2020, up 32.22% quarter-over-quarter from $4.0 million in Q1 2020.
TELA Bio (TELA) Change in Acquisitions & Divestments (2020) Analysis & Trends
TELA Bio's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $5.3 million for Q2 2020.
- In Q2 2020, Change in Acquisitions & Divestments changed N/A year-over-year to $5.3 million; the TTM figure through Dec 2020 stood at $9.3 million (changed N/A YoY), while the FY2020 annual figure was $9.3 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments was $5.3 million for Q2 2020 at TELA Bio, up from $4.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $5.3 million in Q2 2020 to a low of $4.0 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | TELA Bio | 49.36 Mn | 9.81 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 5.29 Mn |
| Jun 30, 2020 | 5.29 Mn |
| Mar 31, 2020 | 4.00 Mn |
| Mar 31, 2020 | 4.00 Mn |